Silence Therapeutics plc

SLN · Nasdaq · SIC 2834: Pharmaceutical Preparations
93
SEC Filings

Business Summary

4 Item 1A. Risk Factors 33 Item 1B. Unresolved Staff Comments 71 Item 1C. Cybersecurity 71 Item 2. Properties 72 Item 3. Legal Proceedings 73 Item 4. Mine Safety Disclosures 73 PART II 74 Item 5. Market for Registrants Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities 74 Item 6. Reserved. 74 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 75 Item 7A. Quantitative and Qualitative Disclosures About Market Risk . 88 It...

Next Earnings

Q2 FY2026 — expected 2026-08-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSLNdiscussed_in_filing Cybersecurity
topic_mentionSLNdiscussed_in_filing Cybersecurity
topic_mentionSLNdiscussed_in_filing Cybersecurity
topic_mentionSLNdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-092591EDGAR81K words
2025-02-272024-12-310000950170-25-029129EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-268116EDGAR23K words
2025-08-072025-06-300000950170-25-104593EDGAR—
2025-05-082025-03-310000950170-25-066439EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001193125-26-092578EDGAR3K words
2025-12-220001193125-25-327575EDGAR—
2025-12-150001193125-25-319156EDGAR—
2025-11-060001193125-25-268102EDGAR—
2025-10-230001193125-25-247692EDGAR—
2025-08-140001193125-25-180313EDGAR—
2025-08-070001193125-25-174958EDGAR—
2025-06-270001193125-25-149704EDGAR—
2025-05-080001193125-25-115533EDGAR—
2025-05-060001193125-25-113364EDGAR—

93 total filings indexed. 78 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001479615
TickerSLN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedX0

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1bd62f3c6ae55df9c6be900e415a107cab65b0afee4ae58e60282b9b5f717169
parent: a380eeb5ec5c9aced79cc97fd95b60aad63c1b306bbe9868768954b8212339b3
content hash: c86c9adccf2b8ad839c2b23e1685313288ad869594bcd9ab102f96c0bb8b31cc
signed: 2026-04-13T04:47:29.015Z
sources: 5 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf